DK0554247T3 - Neurobeskyttende indolon og beslægtede derivater - Google Patents

Neurobeskyttende indolon og beslægtede derivater

Info

Publication number
DK0554247T3
DK0554247T3 DK91905608T DK91905608T DK0554247T3 DK 0554247 T3 DK0554247 T3 DK 0554247T3 DK 91905608 T DK91905608 T DK 91905608T DK 91905608 T DK91905608 T DK 91905608T DK 0554247 T3 DK0554247 T3 DK 0554247T3
Authority
DK
Denmark
Prior art keywords
pct
indolone
neuroprotective
date nov
related derivatives
Prior art date
Application number
DK91905608T
Other languages
Danish (da)
English (en)
Inventor
Bertrand Leo Chenard
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DK0554247T3 publication Critical patent/DK0554247T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK91905608T 1990-05-10 1991-03-04 Neurobeskyttende indolon og beslægtede derivater DK0554247T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52233290A 1990-05-10 1990-05-10
PCT/US1991/001470 WO1991017156A1 (en) 1990-05-10 1991-03-04 Neuroprotective indolone and related derivatives

Publications (1)

Publication Number Publication Date
DK0554247T3 true DK0554247T3 (da) 2000-08-07

Family

ID=24080448

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91905608T DK0554247T3 (da) 1990-05-10 1991-03-04 Neurobeskyttende indolon og beslægtede derivater

Country Status (30)

Country Link
US (1) US5306723A (cg-RX-API-DMAC7.html)
EP (1) EP0554247B1 (cg-RX-API-DMAC7.html)
JP (1) JPH0699423B2 (cg-RX-API-DMAC7.html)
KR (1) KR0163355B1 (cg-RX-API-DMAC7.html)
CN (1) CN1037439C (cg-RX-API-DMAC7.html)
AT (1) ATE192149T1 (cg-RX-API-DMAC7.html)
AU (1) AU642994B2 (cg-RX-API-DMAC7.html)
BR (1) BR9106432A (cg-RX-API-DMAC7.html)
CA (1) CA2080475C (cg-RX-API-DMAC7.html)
CZ (1) CZ280560B6 (cg-RX-API-DMAC7.html)
DE (1) DE69132141T2 (cg-RX-API-DMAC7.html)
DK (1) DK0554247T3 (cg-RX-API-DMAC7.html)
EG (1) EG19647A (cg-RX-API-DMAC7.html)
ES (1) ES2146578T3 (cg-RX-API-DMAC7.html)
FI (1) FI109121B (cg-RX-API-DMAC7.html)
GR (1) GR3034005T3 (cg-RX-API-DMAC7.html)
HU (1) HU221193B1 (cg-RX-API-DMAC7.html)
IE (1) IE911569A1 (cg-RX-API-DMAC7.html)
IL (1) IL98056A (cg-RX-API-DMAC7.html)
MY (1) MY107799A (cg-RX-API-DMAC7.html)
NO (1) NO301979B1 (cg-RX-API-DMAC7.html)
PH (1) PH29902A (cg-RX-API-DMAC7.html)
PL (1) PL169267B1 (cg-RX-API-DMAC7.html)
PT (1) PT97602B (cg-RX-API-DMAC7.html)
RU (1) RU2068414C1 (cg-RX-API-DMAC7.html)
SK (1) SK280833B6 (cg-RX-API-DMAC7.html)
TW (1) TW198720B (cg-RX-API-DMAC7.html)
WO (1) WO1991017156A1 (cg-RX-API-DMAC7.html)
YU (1) YU48528B (cg-RX-API-DMAC7.html)
ZA (1) ZA913494B (cg-RX-API-DMAC7.html)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0788355B2 (ja) * 1991-04-18 1995-09-27 フアイザー・インコーポレイテツド フェノール性2―ピペリジノ―1―アルカノールのプロドラグエステル
US5594007A (en) * 1991-04-18 1997-01-14 Pfizer Inc. Method for treating spinal cord trauma with phenolic 2-piperidino-1-alkanols
BR9206272A (pt) * 1991-07-17 1995-04-11 Pfizer Derivados de 2-(4-hidroxipiperidino)-1-alcanol, como agentes anti-isquêmicos.
FR2688504B1 (fr) * 1992-03-13 1995-05-05 Synthelabo Derives de 2-(piperidin-1-yl)ethanol, leur preparation et leur application en therapeutique.
US5319096A (en) * 1992-04-03 1994-06-07 Hoechst-Roussel Pharmaceuticals Inc. (1H-indol-1-yl)-2-(amino) acetamides and related (1H-indol-1-yl)-(aminoalkyl)amides, pharmaceutical composition and use
US6255322B1 (en) 1992-06-19 2001-07-03 Pfizer Inc. 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents
US5436255A (en) * 1992-07-23 1995-07-25 Pfizer Inc. Method of treating diseases susceptable to treatment by blocking NMDA-receptors
EP0666854B1 (en) * 1992-10-30 1997-03-26 Pfizer Inc. Neuroprotective 3,4-dihydro-2(1h)-quinolone compounds
US5498610A (en) * 1992-11-06 1996-03-12 Pfizer Inc. Neuroprotective indolone and related derivatives
DE69531154T2 (de) * 1994-08-18 2004-04-08 Pfizer Inc. Neuroprotektive 3-(piperidinyl-1)-chroman-4,7-diol und 1-(4-hyphoxyphenyl)-2-(piperidinyl-1)-alkanolderivate
GB9510459D0 (en) 1995-05-24 1995-07-19 Zeneca Ltd Bicyclic amines
ZA9610736B (en) 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
ZA9610741B (en) 1995-12-22 1997-06-24 Warner Lambert Co 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610738B (en) 1995-12-22 1997-06-24 Warner Lambert Co Subtype selective nmda receptor ligands and the use thereof
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
TW427978B (en) * 1996-02-03 2001-04-01 Hoffmann La Roche Tetrahydroisoquinoline derivatives
EP0901490B1 (en) * 1996-05-13 2004-04-07 Syngenta Limited Bicyclic amines as insecticides
GB9623944D0 (en) * 1996-11-15 1997-01-08 Zeneca Ltd Bicyclic amine derivatives
GB9624114D0 (en) * 1996-11-20 1997-01-08 Zeneca Ltd Pesticidal bicyclic amine derivatives
DE69727694T2 (de) 1996-11-26 2004-07-29 Syngenta Ltd., Guildford 8-azabicyclo 3.2.1]octan-, 8-azabicyclo 3.2.1]oct-6-en-, 9-azabicyclo 3.3.1]nonan-, 9-aza-3-oxabicyclo 3.3.1]nonan- und 9-aza-3-thiabicyclo 3.3.1]nonan-derivate, ihre herstellung und ihre verwendung als insektizide
GB9624611D0 (en) 1996-11-26 1997-01-15 Zeneca Ltd Bicyclic amine compounds
EP0846683B1 (en) * 1996-12-03 2001-09-19 F. Hoffmann-La Roche Ag 4-Hydroxy-piperidine derivatives
CA2220649C (en) 1996-12-03 2007-02-13 F. Hoffmann-La Roche Ag 4-hydroxy-piperidine derivatives
JP2002542280A (ja) * 1999-04-27 2002-12-10 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 新規な治療
US6476041B1 (en) 1999-10-29 2002-11-05 Merck & Co., Inc. 1,4 substituted piperidinyl NMDA/NR2B antagonists
US6316474B1 (en) 1999-10-29 2001-11-13 Merck & Co., Inc. 2-benzyl and 2-heteroaryl benzimidazole NMDA/NR2B antagonists
US6380205B1 (en) 1999-10-29 2002-04-30 Merck & Co., Inc. 2-cyclohexyl quinazoline NMDA/NR2B antagonists
US6369076B1 (en) 1999-10-29 2002-04-09 Merck & Co. Inc. 5-benzyl-octahydroindole and 6-benzyl-decahydroquinoline NMDA/NR2B antagonists
US6495561B2 (en) 1999-10-29 2002-12-17 Merck & Co., Inc. 2-cyclohexyl imidazopyridine NMDA/NR2B antagonists
US6291499B1 (en) 1999-10-29 2001-09-18 Merck & Co., Inc. 2-cyclohexyl benzimidazole NMDA/NR2B antagonists
AU1153601A (en) 1999-10-29 2001-05-08 Merck Sharp & Dohme Limited Method to treat pain utilizing benzimidazole NMDA NR2B antagonists
US6489477B1 (en) 1999-10-29 2002-12-03 Merck & Co., Inc. 2-aza-bicyclo[2.2.2]octane NMDA/NR2B antigonists
US6432976B1 (en) 1999-10-29 2002-08-13 Merck & Co., Inc. 8-aza-bicyclo[3.2.1]octane NMDA/NR2B antagonists
US7053089B2 (en) 2001-02-23 2006-05-30 Merck & Co., Inc. N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists
CA2443108A1 (en) 2001-04-03 2002-10-17 Merck & Co. Inc. N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists
US7148236B2 (en) * 2002-01-17 2006-12-12 Merck & Co., Inc. Modulators of acetylcholine receptors
US6713490B2 (en) * 2002-04-26 2004-03-30 Pfizer, Inc. 3,4-dihydroquinolin-2(1H)-one compounds as NR2B receptor antagonists
CA2541162A1 (en) * 2003-10-08 2005-04-21 Pfizer Inc. Fused lactam compounds
US7713990B2 (en) * 2005-01-13 2010-05-11 Neurosearch A/S 3,8-substituted 8-AZA-bicyclo[3.2.1]octane derivatives and their use as monomine neurotransmitter re-uptake inhibitors
US20220218640A1 (en) 2021-01-14 2022-07-14 Rob Dickerman Amino acid delivery system

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3294804A (en) * 1961-01-27 1966-12-27 Sterling Drug Inc 1-(3-hydroxy-3-phenylpropyl)-4-phenyl-4-propionoxy-piperidine
FR5733M (cg-RX-API-DMAC7.html) * 1966-09-27 1968-01-22
JPS51118772A (en) * 1975-04-09 1976-10-18 Otsuka Pharmaceut Co Ltd Method for preparing carbostyryl derivatives
US4082755A (en) * 1977-02-14 1978-04-04 Janssen Pharmaceutica N.V. 1-[(Diarylmethyl)aminoalkyl]piperidimes
WO1980000152A1 (fr) * 1978-07-03 1980-02-07 Sandoz Ag Derives d'un 3-aminopropoxy-aryle, leur preparation et utilisation
PH17194A (en) * 1980-03-06 1984-06-19 Otsuka Pharma Co Ltd Novel carbostyril derivatives,and pharmaceutical composition containing the same
US4358456A (en) * 1980-05-03 1982-11-09 John Wyeth & Brother Limited Antipsychotic piperidinomethyl-indole derivatives
DE3045688A1 (de) * 1980-12-04 1982-07-08 C.H. Boehringer Sohn, 6507 Ingelheim Neue 8-arylalkyl-3-phenyl-3-nortropanole, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu ihrer herstellung
JPS57142972A (en) * 1981-02-27 1982-09-03 Otsuka Pharmaceut Co Ltd Carbostyril derivative
FR2534580A1 (fr) * 1982-10-13 1984-04-20 Synthelabo Derives de phenyl-1 piperidino-2 propanol, leur preparation, et medicaments qui les contiennent
FR2546166B1 (fr) * 1983-05-19 1985-10-25 Synthelabo Enantiomeres du erythro (benzyl-4 piperidino)-2 (hydroxy-4 ou benzyloxy-4 phenyl)-1 propanol, leur preparation et leur application en therapeutique
FR2581993B1 (fr) * 1985-05-14 1988-03-18 Synthelabo Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique
KR910006138B1 (ko) * 1986-09-30 1991-08-16 에자이 가부시끼가이샤 환상아민 유도체
EP0322361A3 (de) * 1987-12-23 1990-01-24 Ciba-Geigy Ag Weitere hydrierte 1-Benzooxacycloalkylpyridincarbonsäureverbindungen
FR2640266B2 (fr) * 1988-07-12 1992-07-10 Synthelabo Derives de (hydroxy-1 piperidinyl-2 alkyl) indolones-2, quinoleinones-2, benzo(b)azepinones-2 et benzimidazolones-2, leur preparation et leur application en therapeutique
EP0398578B1 (en) * 1989-05-17 1997-03-12 Pfizer Inc. 2-piperidino-1-alkanol derivatives as antiischemic agents

Also Published As

Publication number Publication date
AU642994B2 (en) 1993-11-04
PT97602A (pt) 1992-02-28
PL169267B1 (pl) 1996-06-28
TW198720B (cg-RX-API-DMAC7.html) 1993-01-21
YU48528B (sh) 1998-11-05
EP0554247A1 (en) 1993-08-11
PH29902A (en) 1996-09-16
IL98056A (en) 1995-11-27
DE69132141D1 (de) 2000-05-31
NO301979B1 (no) 1998-01-05
CN1056497A (zh) 1991-11-27
AU7456591A (en) 1991-11-27
CZ280560B6 (cs) 1996-02-14
CA2080475C (en) 2001-04-17
JPH0699423B2 (ja) 1994-12-07
PT97602B (pt) 1998-08-31
KR0163355B1 (ko) 1998-12-01
HU221193B1 (en) 2002-08-28
WO1991017156A1 (en) 1991-11-14
IL98056A0 (en) 1992-06-21
ATE192149T1 (de) 2000-05-15
IE911569A1 (en) 1991-11-20
FI925069A0 (fi) 1992-11-09
HU9203515D0 (en) 1993-01-28
CS135491A3 (en) 1992-05-13
EG19647A (en) 1995-08-30
RU2068414C1 (ru) 1996-10-27
CA2080475A1 (en) 1991-11-11
NO924310L (no) 1992-11-09
ES2146578T3 (es) 2000-08-16
ZA913494B (en) 1992-12-30
EP0554247B1 (en) 2000-04-26
YU81091A (sh) 1993-11-16
GR3034005T3 (en) 2000-11-30
FI925069L (fi) 1992-11-09
US5306723A (en) 1994-04-26
BR9106432A (pt) 1993-05-04
DE69132141T2 (de) 2000-09-21
MY107799A (en) 1996-06-29
FI109121B (fi) 2002-05-31
HUT62879A (en) 1993-06-28
NO924310D0 (no) 1992-11-09
SK280833B6 (sk) 2000-08-14
KR930700482A (ko) 1993-03-15
CN1037439C (zh) 1998-02-18
JPH05506433A (ja) 1993-09-22

Similar Documents

Publication Publication Date Title
DK0554247T3 (da) Neurobeskyttende indolon og beslægtede derivater
NO306346B1 (no) N-substituerte azabicykloalkanderivater, anvendelse derav og farmasöytisk preparat
ATE131051T1 (de) Indolderivate, die die leukotrienbiosynthese hemmen.
RU92016415A (ru) Нейрозащитные производные индолона и родственные производные
DE69516503D1 (de) Piperidinderivate mit paf antagonistischer wirkung
NO853698L (no) I-substituerte tetralinderivater, fremstilling og anvendel se derav.
ATE189458T1 (de) Dipeptidische p-amidinobenzylamide mit n- terminalen sulfonyl- bzw. aminosulfonylresten
DK0782567T3 (da) Isothiourinstofderivater og fremgangsmåder til deres fremstilling
NO306400B1 (no) N-substituerte azabicykloheptan-derivater, anvendelse derav og farmasöytisk preparat
NO923226D0 (no) Nytt beta-fenylisoserinderivat, dets fremstilling og anvendelse
MX9303605A (es) Derivados de azabicicloheptano n-substituidas, su obtencion y uso.
ES2095058T3 (es) Derivados del 3-azabiciclo(3.2.0)heptano substituidos como productos intermedios.
FI933883A0 (fi) Nya 1-aryl-4-piperazinyl-cyclohexankarboxylsyranitriler, deras framstaellning och anvaendning